4.7 Article

Central pressure: Variability and impact of cardiovascular risk factors - The Anglo-Cardiff Collaborative Trial II

Journal

HYPERTENSION
Volume 51, Issue 6, Pages 1476-1482

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.107.105445

Keywords

central pressure; brachial pressure; pulse pressure ratio; pulse pressure amplification; hypertension; cardiovascular risk factors

Funding

  1. British Heart Foundation [FS/07/001/21990] Funding Source: researchfish
  2. British Heart Foundation [FS/07/001/21990] Funding Source: Medline

Ask authors/readers for more resources

Pulse pressure varies throughout the arterial tree, resulting in a gradient between central and peripheral pressure. Factors such as age, heart rate, and height influence this gradient. However, the relative impact of cardiovascular risk factors and atheromatous disease on central pressure and the normal variation in central pressure in healthy individuals are unclear. Seated peripheral (brachial) and central (aortic) blood pressures were assessed, and the ratio between aortic and brachial pulse pressure (pulse pressure ratio, ie, 1/amplification) was calculated in healthy individuals, diabetic subjects, patients with cardiovascular disease, and in individuals with only 1 of the following: hypertension, hypercholesterolemia, or smoking. The age range was 18 to 101 years, and data from 10 613 individuals were analyzed. Compared with healthy individuals, pulse pressure ratio was significantly increased (ie, central systolic pressure was relatively higher) in individuals with risk factors or disease (P 0.01 for all of the comparisons). Although aging was associated with an increased pulse pressure ratio, there was still an average+/-SD difference between brachial and aortic systolic pressure of 11+/-4 and 8+/-3 mm Hg for men and women aged >80 years, respectively. Finally, stratifying individuals by brachial pressure revealed considerable overlap in aortic pressure, such that >70% of individuals with high-normal brachial pressure had similar aortic pressures as those with stage 1 hypertension. These data demonstrate that cardiovascular risk factors affect the pulse pressure ratio, and that central pressure cannot be reliably inferred from peripheral pressure. However, assessment of central pressure may improve the identification and management of patients with elevated cardiovascular risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Critical Care Medicine

Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease

Marie Fisk, Ian Wilkinson

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Peripheral Vascular Disease

Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement

Luca Zanoli, Dimitri P. Mikhailidis, Rosa Maria Bruno, Maria T. Abreu, Silvio Danese, Rami Eliakim, Paolo Gionchetti, Konstantinos H. Katsanos, Julien Kirchgesner, Ioannis E. Koutroubakis, Torsten Kucharzik, Peter L. Lakatos, Geoffrey C. Nguyen, Alfredo Papa, Stephan R. Vavricka, Ian B. Wilkinson, Pierre Boutouyrie

ANGIOLOGY (2020)

Review Hematology

Uses of Arterial Stiffness in Clinical Practice

Ian B. Wilkinson, Kaisa M. Maki-Petaja, Gary F. Mitchell

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Geriatrics & Gerontology

Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease

Jilles M. Fermont, Divya Mohan, Marie Fisk, Charlotte E. Bolton, William Macnee, John R. Cockcroft, Carmel McEniery, Jonathan Fuld, Joseph Cheriyan, Ruth Tal-Singer, Hana Mullerova, Angela M. Wood, Ian B. Wilkinson, Michael Polkey

Summary: The study found that using the SPPB and its components as an alternative to the 6MWT in the BODE Index maintained a similar predictive ability for mortality in COPD patients.

AGE AND AGEING (2021)

Article Peripheral Vascular Disease

Psychological Wellbeing and Aortic Stiffness Longitudinal Study

Ai Ikeda, Andrew Steptoe, Martin Shipley, Ian B. Wilkinson, Carmel M. McEniery, Takeshi Tanigawa, Archana Singh-Manoux, Mika Kivimaki, Eric J. Brunner

HYPERTENSION (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Consensus Recommendations on the Use of 18F-FDG PET/CT in Lung Disease

Delphine L. Chen, Safia Ballout, Laigao Chen, Joseph Cheriyan, Gourab Choudhury, Ana M. Denis-Bacelar, Elise Emond, Kjell Erlandsson, Marie Fisk, Francesco Fraioli, Ashley M. Groves, Roger N. Gunn, Jun Hatazawa, Beverley F. Holman, Brian F. Hutton, Hidehiro Iida, Sarah Lee, William MacNee, Keiko Matsunaga, Divya Mohan, David Parr, Alaleh Rashidnasab, Gaia Rizzo, Deepak Subramanian, Ruth Tal-Singer, Kris Thielemans, Nicola Tregay, Edwin J. R. van Beek, Laurence Vass, Marcos F. Vidal Melo, Jeremy W. Wellen, Ian Wilkinson, Frederick J. Wilson, Tilo Winkler

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Medicine, General & Internal

Maternal Cardiovascular Dysfunction is Associated with Hypoxic Cerebral and Umbilical Doppler Changes

Giulia Masini, Jasmine Tay, Carmel M. McEniery, Ian B. Wilkinson, Herbert Valensise, Grazia M. Tiralongo, Daniele Farsetti, Wilfried Gyselaers, Sharona Vonck, Christoph C. Lees

JOURNAL OF CLINICAL MEDICINE (2020)

Article Biophysics

Towards the non-invasive determination of arterial wall distensible properties: New approach using old formulae

Ye Li, Alessandro Giudici, Ian B. Wilkinson, Ashraf W. Khir

Summary: Arterial function and wall mechanical properties play crucial roles in circulation hemodynamics. A novel non-invasive method for determining vessel distensibility and elastic modulus was proposed and validated, showing comparable results to invasive techniques. This new approach holds potential for clinical applications.

JOURNAL OF BIOMECHANICS (2021)

Article Medicine, General & Internal

Trial of Dexamethasone for Chronic Subdural Hematoma

Peter J. Hutchinson, Ellie Edlmann, Diederik Bulters, Ardalan Zolnourian, Patrick Holton, Nigel Suttner, Kevin Agyemang, Simon Thomson, Ian A. Anderson, Yahia Z. Al-Tamimi, Duncan Henderson, Peter C. Whitfield, Monica Gherle, Paul M. Brennan, Annabel Allison, Eric P. Thelin, Silvia Tarantino, Beatrice Pantaleo, Karen Caldwell, Carol Davis-Wilkie, Harry Mee, Elizabeth A. Warburton, Garry Barton, Aswin Chari, Hani J. Marcus, Andrew T. King, Antonio Belli, Phyo K. Myint, Ian Wilkinson, Thomas Santarius, Carole Turner, Simon Bond, Angelos G. Kolias

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Rheumatology

Baricitinib set to join the Covid-19 therapeutic arsenal?

Tania Gudu, Carmel Stober, Andrew P. Cope, Joseph Cheriyan, James Galloway, Ian B. Wilkinson, Michalis Kostapanos, David Jayne, Frances Hall

RHEUMATOLOGY (2021)

Article Peripheral Vascular Disease

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension The HYPAZ Trial

Kaisa M. Maki-Petaja, Adam McGeoch, Lucy L. Yang, Annette Hubsch, Carmel M. McEniery, Paul A. R. Meyer, Fraz Mir, Parag Gajendragadkar, Nicola Ramenatte, Gayathri Anandappa, Sara Santos Franco, Simon J. Bond, Carola-Bibiane Schonlieb, Yoeri Boink, Christoph Brune, Ian B. Wilkinson, Duncan Jodrell, Joseph Cheriyan

Summary: The study found that in patients receiving the VEGF inhibitor pazopanib, the drug led to hypertension, possibly through increasing peripheral vascular resistance and reducing microvascular density and diameter.

HYPERTENSION (2021)

Review Pharmacology & Pharmacy

Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19

Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David R. W. Jayne, James Galloway, Frances Hall, Ian B. Wilkinson, Philip Ambery, Joseph Cheriyan

Summary: Treatment of COVID-19 requires a multi-faceted approach, and a combined therapeutic regimen of endothelin-A receptor antagonists and sodium glucose co-transporter-2 inhibitors may have beneficial effects in mitigating the manifestations of the disease. Randomized controlled clinical trials are needed to determine the efficacy and safety of these medicines in treating COVID-19.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Medicine, General & Internal

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study

Paul J. Cacciottolo, Michalis S. Kostapanos, Elena Hernan Sancho, Holly Pavey, Fotini Kaloyirou, Evangelia Vamvaka, Joanna Helmy, Annette Hubsch, Carmel M. McEniery, Ian B. Wilkinson, Joseph Cheriyan

Summary: This study aims to investigate the physiological mechanisms of cardiovascular benefits of LDL-C lowering through PCSK9 inhibition in patients with established cardiovascular disease. The study will observe changes in measures of endothelial function and vascular inflammation imaging following intervention. Participants will be randomly assigned to alirocumab or ezetimibe treatment groups and undergo repeat scans and assessments after 8 weeks.

BMJ OPEN (2021)

Editorial Material Peripheral Vascular Disease

CONNed in Pregnancy

Spoorthy Kulkarni, Anna F. Dominiczak, Rhian M. Touyz, J. David Spence, Daniel Batlle, Mohammed Barigou, Morris Brown, Robert M. Carey, Fernando Elijovich, Sandra Taler, Ian B. Wilkinson

HYPERTENSION (2021)

Review Engineering, Biomedical

Review of the Techniques Used for Investigating the Role Elastin and Collagen Play in Arterial Wall Mechanics

Alessandro Giudici, Ian B. Wilkinson, Ashraf W. Khir

Summary: The arterial wall is composed of various components such as collagen and elastin fibers, proteoglycans, Vascular Smooth Muscle Cells (VSMCs) and ground matrix, which play different roles in determining the mechanical properties of the vascular tissue. Experimental methods including microscopy imaging and mechanical testing have been used to study the mechanical role of these structural proteins, but combining these methods provides a more complete understanding of the arterial micromechanics. Advances in imaging techniques allow for dynamic imaging of samples under a pseudo-physiological condition, overcoming the limitations of using either method separately. This review aims to describe the techniques available for studying arterial wall micromechanics and to identify gaps in current research on arterial mechanics.

IEEE REVIEWS IN BIOMEDICAL ENGINEERING (2021)

No Data Available